Strategic Partnerships Expression Therapeutics is actively collaborating with Stanford Medicine, indicating openness to co-development opportunities and access to world-class research networks that could accelerate joint programs and expand pilot opportunities.

Northwest Manufacturing With state-of-the-art manufacturing facilities in Ohio (Butler County and Cincinnati) and a recent expansion, there is potential to offer contract manufacturing, fill-finish services, and supply partnerships for cell and gene therapies targeting hematology and oncology.

Clinical Stage As a fully integrated clinical-stage company developing gene and cell therapies, Expression Therapeutics presents opportunities for early-access programs, clinical trial collaborations, and supplier partnerships across GMP manufacturing, quality systems, and vector production.

Hemophilia Focus The company’s emphasis on liver-targeting hemophilia A gene therapies and existing technology licensing ties offer potential for strategic licensing deals, co-development arrangements, or risk-sharing partnerships with complementary hematology players.

Growth Potential A revenue range of 10–25M and a lean employee base suggest scalability opportunities for CRO/CMO alignment, venture-backed partner engagement, and scalable platform collaborations to broaden portfolio in oncology and hematology markets.